Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trialJingxin Li, Fengcai Zhu, Wei Chen et al.|Nature Medicine|2022Cited by 163
Heterologous prime-boost immunization with CoronaVac and ConvideciaJingxin Li, Fengcai Zhu, Jiahong Zhu et al.|medRxiv|2021Cited by 33
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trialLairun Jin, Fengcai Zhu, Lihua Hou et al.|Emerging Microbes & Infections|2022Cited by 30
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previouslyLairun Jin, Fengcai Zhu, Lihua Hou et al.|medRxiv|2022Cited by 10